Gut chemosensing mechanisms

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 908-917

  Psichas, Arianna ^a   Reimann, Frank ^a   Gribble, Fiona M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; SOMATOSTATIN; GASTROINTESTINAL HORMONE;

ADAPTIVE IMMUNITY; CALORIC RESTRICTION; CELL INTERACTION; COLON MUCOSA; CONFOCAL MICROSCOPY; CYTOPLASM; ENTEROENDOCRINE CELL; EPITHELIUM CELL; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SECRETION; GASTROINTESTINAL TRACT; GENETIC TRANSCRIPTION; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; HOST RESISTANCE; HUMAN; INTESTINE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INNERVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; SMALL INTESTINE; SWEETNESS; ANIMAL; CYTOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; ENTERIC NERVOUS SYSTEM; ENTEROENDOCRINE CELLS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, INNATE; MICROBIOTA;

EID: 84924070363     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76309     Document Type: Review

References (150)

1. Holst J. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol. 2013;13(6):983-988.
2. Bohórquez D, Chandra R, Samsa L, Vigna S, Liddle R. Characterization of basal pseudopodlike processes in ileal and colonic PYY cells. J Mol Histol. 2011;42(1):3-13.
3. Liou A, et al. The G-protei n-coupled receptor GPR40 directly mediates long-chain fatty acidinduced secretion of cholecystokinin. Gastroenterology. 2011;140(3):903-912.
4. Parker H, Habib A, Rogers G, Gribble F, Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia. 2009;52(2):289-298.
5. Reimann F, et al. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008;8(6):532-539.
6. Habib A, et al. Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology. 2012;153(7):3054-3065.
7. Egerod K, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153(12):5782-5795.
8. Engelstoft M, Egerod K, Lund M, Schwartz T. Enteroendocrine cell types revisited. Curr Opin Pharmacol. 2013;13(6):912-921.
9. Sjölund K, Sandén G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology. 1983;85(5):1120-1130.
10. van der Wielen N, et al. Cross-species comparison of genes related to nutrient sensing mechanisms expressed along the intestine. PLoS One. 2014;9(9):e107531.
11. Bado A, et al. The stomach is a source of leptin. Nature. 1998;394(6695):790-793.
12. Cammisotto P, Bendayan M. A review on gastric leptin: the exocrine secretion of a gastric hormone. Anat Cell Biol. 2012;45(1):1-16.
13. Mix H, et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut. 2000;47(4):481-486.
14. Brubaker P. Regulation of intestinal proglucagonderived peptide secretion by intestinal regulatory peptides. Endocrinology. 1991;128(6):3175-3182.
15. Schubert M. Gastric secretion. Curr Opin Gastroenterol. 2010;26(6):598-603.
16. Date Y,et al Ghrelin, a novel growth hormonereleasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans Endocr inology. 2000, 141, 11, 4255-4261.
17. Kirchner H, Heppner KM, Tschop MH. The role of ghrelin in the control of energy balance. Handb Exp Pharmacol. 2012;(209):161-184.
18. Verhulst PJ, Depoortere I. Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol. 2012;18(25):3183-3195.
19. Rasmussen BA, et al. Jejunal leptin-PI3K signaling lowers glucose production. Cell Metab. 2014;19(1):155-161.
20. Grosse J, et al. Insulin-like peptide 5 is an orexigenic gastrointestinal hormone. Proc Natl Acad Sci U S A. 2014;111(30):11133-11138.
21. Eissele R, et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest. 1992;22(4):238-291.
22. Cox HM. Peptide YY: a neuroendocrine neighbor of note. Peptides. 2007;28(2):345-351.
23. Larsson L, Holst J, Hå kanson R, Sundler F. Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry. 1975;44(4):281-290.
24. Bohórquez D, et al. An enteroendocrine cellenteric glia connection revealed by 3D electron microscopy. PLoS One. 2014;9(2):e89881.
25. Tolhurst G, et al. Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology. 2011;152(2):405-413.
26. Chaikomin R, et al. Effects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men. Regul Pept. 2008;150(1):38-42.
27. Hasegawa H, et al. Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patient s with non-insulin-dependent diabetes mellitus. Metabolism. 1996;45(2):196-202.
28. Parker BA, Doran S, Wishart J, Horowitz M, Chapman IM. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf). 2005;62(5):539-546.
29. Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol. 1997;34(1):18-21.
30. Shima K, Suda T, Nishimoto K, Yoshimoto S. Relat ionship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops. Acta Endocrinol (Copenh). 1990;123(4):464-470.
31. Sykes S, M organ L, English J, Marks V. Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. J Endocrinol. 1980;85(2):201-207.
32. Gribble F, Williams L, Simpson A, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes. 2003;52(5):1147-1154.
33. Parker H, et al. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia. 2012;55(9):2445-2455.
34. Gorboulev V, et al. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012;61(1):187-196.
35. Powell D, et al. LX4211 increases serum glucagonlike peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther. 2013;345(2):250-259.
36. Stephens J, et al. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Res Clin Pra ct. 2011;94(2):199-206.
37. Kuhre R,et al Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans Am J Physiol Gastrointest Liver Physiol. 2014 306 7, G622-G630.
38. Jang H, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A. 2007;104(38):15069-15074.
39. Margolskee R, et al. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A. 2007;104(38):15075-15080.
40. Young R, et al. Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes. Diabetes. 2013;62(10):3532-3541.
41. Geraedts MC, et al. Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery. Am J Physiol Endocrinol Metab. 2012;303(4):E464-E474.
42. Fujita Y, et al. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab. 2009;296(3):E473-E479.
43. Ma J, et al. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009;296(4):G735-G739.
44. Batterham R, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006;4(3):223-233.
45. Reimann F, Williams L, da Silva Xavier G, Rutter G, Gribble F. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia. 2004;47(9):1592-1601.
46. Greenfield J, et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr. 2009;89(1):106-113.
47. Mace O, Schindler M, Patel S. The regulation of K-And L-cell activity by GLUT2 an d the calciumsensing receptor CasR in rat small intestine. J Physiol. 2012;590(pt 12):2917-2936.
48. Engelstoft MS, et al. Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. Mol Metab. 2013;2(4):376-392.
49. Liou A, et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol. 2011;300(4):G538-G546.
50. Wang J, et al. Umami receptor activation increases duodenal bicarbonate secretion via glucagonlike peptide-2 release in rats. J Pharmacol Exp Ther. 2011;339(2):464-473.
51. Oya M, et al. The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secreti on from GLUTag cells. J Biol Chem. 2013;288(7):4513-4521.
52. Cordier-Bussat M, et al. Peptones stimulate both the secretion of the incretin hormone glucagonlike peptide 1 and the transcription of the p roglucagon gene. Diabetes. 1998;47(7):1038-1045.
53. Reimer R, et al. A human cellular model for studying the regulation of glucagonlike peptide-1 secretion. Endocrinology. 2001;142(10):4522-4528.
54. Liou A, et al. Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. Am J Physiol Gastroin test Liver Physiol. 2011;300(5):G895-G902.
55. Matsumura K, Miki T, Jhomori T, Gonoi T, Seino S. Possible role of PEPT1 in gastrointestinal hormone secretion. Biochem Biophys Res Commun. 2005;336(4):1028-1032.
56. Diakogiannaki E, et al. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia. 2 013;56(12):2688-2696.
57. Choi S, et al. GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells. Am J Physiol Gastrointest Liver Physiol. 2007;292(5):G1366-G1375.
58. Elliott R, et al. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretio n patterns. J Endocrinol. 1993;138(1):159-166.
59. Liddle R, Goldfine I, Rosen M, Taplitz R, Williams J. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, an d relationship to gallbladder contraction. J Clin Invest. 1985;75(4):1144-1152.
60. Spiller R, et al. Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partia l digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut. 1988;29(8):1042-1051.
61. Hirasawa A, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11(1):90-94.
62. Chu Z, et al. A role for intes tinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagonlike Peptide-1 and glucose-dependent insulinotropic Peptide release. Endocrinology. 2008;149(5):2038-2047.
63. Lauffer L, Iakoubov R, Brubaker P. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes. 2009;58(5):1058-1066.
64. Edfalk S, Steneberg O, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008;57(9):2280-2287.
65. Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci. 2011;100(9):3594-3601.
66. Ha bib A, Richards P, Rogers G, Reimann F, Gribble F. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. Diabetologia. 2013;56(6):1413-1416.
67. Hansen K, et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab. 2011;96(9):E1409-E1417.
68. Cox H, et al. Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab. 2010;11(6):532-542.
69. Overton H, et al. Deorphanization of a G proteincoupled receptor for ole oylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006;3(3):167-175.
70. Drucker D, Jin T, Asa S, Young T, Brubaker P. Activation of proglucag on gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol. 1994;8(12):1646-1655.
71. Islam D, et al. Epac is involved in cAMP-stimulated proglucagon expres sion and hormone production but not hormone secretion in pancreatic alpha-And intestinal L-cell lines. Am J Physiol Endocrinol Metab. 2009;296(1):E174-E181.
72. Simpson A, et al. Cyclic AMP triggers glucagonlike peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia. 2007;50(10):2181-2189.
73. Katz L, et al. Effects of JNJ-38431055, a novel GPR119 receptor agonist, in rand omized, double-blind, placebo-controlled studies in subjects with type 2 diabetes. Diabetes Obes Metab. 2012;14(8):709-716.
74. Poreba M, et al. Role of fatty acid transport protein 4 in oleic acid-indu ced glucagon-like peptide-1 secretion from murine intestinal L cells. Am J Physiol Endocrinol Metab. 2012;303(7):E899-E907.
75. Iakoubov R, Ahmed A, Lauffer L, Bazinet R, Brubaker P. Essential role for protein kinase C? in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology. 2011;152(4):1244-1252.
76. Fatma S, Yakubov R, Anwar K, Hussain M. Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion. J Lipid Res. 2006;47(11):2422-2 432.
77. Shimotoyodome A, et al. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice. Endocrinology. 2009;150( 5):2118-2126.
78. Lu W, et al. Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP. Lipids. 2012;47(6):571-580.
79. Chandra R, et al. Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion. J Clin Invest. 2013;123(8):3343-3352.
80. Okawa M,et al Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion Biochem Biophys Res Commun. 2009, 390, 3, 377-381.
81. Hata T, et al. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a diet ary fat-dependent manner. J Pharmacol Exp Ther. 2011;336(3):850-856.
82. Flock G, Cao X, Maziarz M, Drucker D. Activation of enteroendocrine membrane progesterone receptors promotes incretin sec retion and improves glucose tolerance in mice. Diabetes. 2013;62(1):283-290.
83. Franckhauser S, et al. Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia. 2008;51(7):1306-1316.
84. Holmes A, et al. Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR? and UCP2 expression in rats. J Endocrinol. 2008;198(2):367-374.
85. Adam T, Westerterp-Plantenga M. Activityinduced GLP-1 release in lean and obese subjects. Physiol Behav. 2004;83(3):459-466.
86. Martins C, Morgan L, Bloom S, Robertson M. Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol. 2007;193(2):251-258.
87. Ellingsgaard H, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17(11):1481-1489.
88. Adrian T, et al. Rectal taurocholate increase s L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia. 2012;55(9):2343-2347.
89. Wu T, et al. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans. J Clin Endocrinol Metab. 2013;98(4):E718-E722.
90. Patti M, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17(9):1671-1677.
91. Pournaras D, et al. The role of bile after Rouxen-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153(8):3613-3619.
92. Parker H, et al. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol. 2012;165(2):414-423.
93. Thomas C, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10(3):167-177.
94. Moss C, et al. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypepti de from intestinal K cells in rodents. Diabetologia. 2012;55(11):3094-3103.
95. Batterham RL, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941-948.
96. Degen L, et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol. 2007;292(4):R1391-R1399.
97. Rudovich NN, et al. Metabolomic linkage reveals functional interaction between glucosedependent insulinotropic polypeptide and ghrelin in humans. Am J Physiol Endocrinol Metab. 2011;301(4):E608-E617.
98. Backhed F, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718-15723.
99. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-1023.
100. Ridaura VK, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214.
101. Turnbaugh PJ,et al An obesity-Associated gut microbiome with increased capacity for energy harvest Nature. 2006 444 7122, 1027-1031.
102. Brown A, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312-113 19.
103. Le Poul E, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481-25489.
104. Karaki S, et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 2006;324(3):353-360.
105. Karaki S, et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008;39(2):135-142.
106. Tazoe H, et al. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009;30(3):149-156.
107. Nøhr M, et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neuro ns and FFAR2 in enteric leukocytes. Endocrinology. 2013;154(10):3552-3564.
108. Tolhurst G, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364-371.
109. Seljeset S, Siehler S. Receptor-specific regulation of ERK1/2 activation by members of the " free fatty acid receptor" family. J Recept Signal Transduct Res. 2012;32(4):196-201.
110. Lim G, et al. Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology. 2009;150(2):580-591.
111. Psichas A, et al. The short chain fatty acid propionate stimulates GLP-1 PYY secretion via free fatty acid receptor 2 in rodents [published online ahead of print August 11, 2014]. Int J Obes (Lond). doi:10.1038/ijo. 2014.153.
112. Sykaras A, Demenis C, Case R, McLaughlin J, Smith C. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One. 2012;7( 8):e42373.
113. Clarke G, et al. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8):1221-1238.
114. Nicholson JK, et al. Host-gu t microbiota metabolic interactions. Science. 2012;336(6086):1262-1267.
115. Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F. Bacterial metabolite indole modulates incre tin secretion from intestinal enteroendocrine L-cells. Cell Rep. 2014;9(4):1202-1208.
116. Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagonlike peptide-2. Annu Rev Physiol. 2014;76:561-583.
117. Bogunovic M, et al. Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol. 2007;292(6):G1770-G1783.
118. Palazzo M, et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol. 2007;178(7):4296-4303.
119. Selleri S, et al. Induction of pro-inflammatory programs in enteroendocrine cell s by the Tolllike receptor agonists flagellin and bacterial LPS. Int Immunol. 2008;20(8):961-970.
120. Akhtar M, Watson JL, Nazli A, McKay DM. Bacterial DNA evokes epithelial IL-8 productio n by a MAPK-dependent, NF-?B-independent pathway. FASEB J. 2003;17(10):1319-1321.
121. Suzuki M, Hisama tsu T, Podolsky DK. ?-Interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like recept or 4-MD-2 complex. Infect Immun. 2003;71(6):3503-3511.
122. McDermott JR, et al. Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation. Gut. 2006;55(4):492-497.
123. Reimann F, Tolhurst G, Gribble F. G-proteincoupled receptors in intestinal chemosensation. Cell Metab. 2012;15(4):421-431.
124. Hansen L, Lampert S, Mineo H, Holst J. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab. 2004;287(5):E939-E947.
125. Anini Y, Hansotia T, Brubaker P. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology. 2002;143(6):2420-2426.
126. Herrmann-Rin ke C, McGregor G, Göke B. Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum. Peptides. 2000;21(3):431-437.
127. Ghatei M, et al. Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab. 1982;54(5):980-985.
128. Jensen R, Battey J, Spindel E, Benya R. International Union of Pharma cology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev. 2008;60(1):1-42.
129. Persson K, et al. Reduc ed GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. Am J Physiol Endocrinol Metab. 2000;279(5):E956-E962.
130. Chang C, Chey W, Braggins L, Coy D, Chang T. Pituitary adenylate cyclase-Activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. Am J Physiol. 1996;271(3):G516-G523.
131. Vaudry D, et al. Pituitary adenylate cyclaseactivating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52(2):269-324.
132. Herrmann-Rinke C, Hörsch D, McGregor G, Göke B. Galanin is a potent inhibitor of glucagonlike peptide-1 secretion from rat ileum. Peptides. 1996;17(4):571-576.
133. Chang C, Chey W, Coy D, Chang T. Galanin inhibits cholecystokinin secretion in STC-1 cells. Biochem Biophys Res Commun. 1995;216(1):20-25.
134. Saïfia S, et al. Galanin inhibits glucagon-like peptide-1 secretion through pertussi s toxinsensitive G protein and ATP-dependent potassium channels in rat ileal L-cells. J Endocrinol. 1998;157(1):33-41.
135. Bauer F, et al. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology. 1989;97(2):260-264.
136. Fang P, Bo P, Shi M, Yu M, Zhang Z. Circulating galanin levels are increased in patients with gestational diabetes mellitus. Clin Biochem. 2013;46(9):831-833.
137. Legakis I, Mantzouridis T, Mountokalakis T. Positive correlation of galanin with glucose in type 2 diabetes. Diabetes Care. 2005;28(3):759-760.
138. Coutts A, Irving A, Mackie K, Pertwee R, Anavi-Goffer S. Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol. 2002;448(4):410-422.
139. Ló pez-Redondo F, Lees G, Pertwee R. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guineapig ileum. Br J Pharmacol. 1997;122(2):330-334.
140. Richards P, et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes. 2014;63(4):1224-1233.
141. Amato A, et al. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol Motil. 2010;22(6):664-e203.
142. de Heuvel E, Wallace L, Sharkey K, Sigalet D. Glucagon-like peptide 2 induces vasoactive intestinal polypeptide expression in enteric neurons via phophatidylinositol 3-kinase-? signaling. Am J Physiol Endocrinol Metab. 2012; 303(8):E994-E1005.
143. Patterson L, Zheng H, Berthoud H. Vagal afferents innervating the gastrointestinal tract and CCKA-receptor immunoreactivity. Anat Rec. 2002;266(1):10-20.
144. Bertrand P,Kunze W,Bornstein J,Furness J,Smith M Analysis of the responses of myenteric neurons in the small intestine to chemical stimulation of the mucosa Am J Physiol. 1997 273 2): G422-G435.
145. Neunlist M, Dobreva G, Schemann M. Characteristics of mucosally projecting myenteric neurones in the guinea-pig proximal colon. J Physiol. 1999;517(pt 2):533-546.
146. Soret R, et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology. 2010;138(5):1772-1782.
147. Furness J, Rive ra L, Cho H, Bravo D, Callaghan B. The gut as a sensory organ. Nat Rev Gastroenterol Hepatol. 2013;10(12):729-740.
148. Liu M, Seino S, Kirchgessner A. Identification and characterization of glucoresponsive neurons in the enteric nervous system. J Neurosci. 1999;19(23):10305-10317.
149. Neunlist M, Schemann M. Nutrient-induced changes in the phenotype and function of the enteric nervous system. J Physiol. 2014; 592(pt 14):2959-2965.
150. Poole D, et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil. 2010;22(7):814-825.